References

  1. Mignon A, Dreyfus M, Ozier Y. Prise en charge initiale par l’anesthésiste en cas d’hémorragie du post-partum. Journal de gynécologie obstétrique et biologie de la reproduction. 2004;33(8):65-72. PubMed | Google Scholar

  2. Leduc D, Senikas V, Lalonde AB, Ballerman C, Biringer A, Delaney M, et al. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. Journal of obstetrics and gynaecology Canada: JOGC= Journal d'obstetrique et gynecologie du Canada: JOGC. 2009;31(10):980-93. PubMed | Google Scholar

  3. Pasquier P, Gayat E, Rackelboom T, La Rosa J, Tashkandi A, Tesniere A, et al. An observational study of the fresh frozen plasma: red blood cell ratio in postpartum hemorrhage. Anesthesia & Analgesia. 2013;116(1):155-61. PubMed | Google Scholar

  4. Goffinet F, Mercier F, Teyssier V, Pierre F, Dreyfus M, Mignon A, et al. [Postpartum haemorrhage: recommendations for clinical practice by the CNGOF (December 2004)]. Gynecologie, obstetrique & fertilite. 2005;33(4):268-7. PubMed | Google Scholar

  5. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. The lancet. 2006; 367(9516):1066-74. PubMed | Google Scholar

  6. Rath WH. Postpartum hemorrhage–update on problems of definitions and diagnosis*. Acta obstetricia et gynecologica Scandinavica. 2011;90(5):421-8. PubMed | Google Scholar

  7. SFAR (Société Française d’Anesthésie et de Réanimation) QFP: Transfusion massive. [Consulté le 07/12/2013].Disponible à partir de URL: http://www.sfar.org/article/999/qfp-transfusion-massive. Google Scholar

  8. Onwuemene O, Green D, Keith L. Postpartum hemorrhage management in 2012: predicting the future. International Journal of Gynecology & Obstetrics. 2012;119(1):3-5. PubMed | Google Scholar

  9. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. Journal of Trauma-Injury Infection and Critical Care. 2007; 63(4):805-13. PubMed | Google Scholar

  10. Godier A, Ozier Y, Susen S, editors. [1/1 plasma to red blood cell ratio: an evidence-based practice?]. Annales françaises d'anesthésie et de réanimation. 2011; 30:421-8. PubMed | Google Scholar

  11. Sperry JL, Ochoa JB, Gunn SR, Alarcon LH, Minei JP, Cuschieri J, et al. An FFP: PRBC transfusion ratio? 1: 1.5 is associated with a lower risk of mortality after massive transfusion. Journal of Trauma and Acute Care Surgery. 2008;65(5):986-93. PubMed | Google Scholar

  12. Bonnet M, Tesniere A, Mignon A. [Transfusion for post-partum haemorrhage: what's new in 2011?]. Transfusion clinique et biologique: journal de la Société française de transfusion sanguine. 2011;18(2):129-32. PubMed | Google Scholar

  13. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis. 2007;5(2):266-73. PubMed | Google Scholar

  14. David JS, Levrat A, Macabeo C, Clevenot D, Gueugniaud PY. Stratégie transfusionnelle. Congrès National d’Anesthésie et de Réanimation 2008. Urgences vitales: 665-675. [consulté le 07/03/2015].disponible a partir de URL: http://www.sfar.org/acta/dossier/archives/mu08/html/mu08_07/ca08_44.htm. Google Scholar

  15. Ducloy-Bouthors A-S, Blondé-Zoonekynd É, Jaillette E, Richart P, Barre-Drouard C, Wibaut B, et al. Transfusion et hémorragie du post-partum. Transfusion clinique et biologique. 2010;17(5):273-8. PubMed | Google Scholar

  16. Johansson PI, Stensballe j, Rosenberg J, Hilsløv TL, Jørgensen I, Secher NH. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion. 2007;47(4):593-8. PubMed | Google Scholar

  17. Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz R-C, Bouvier-Colle M-H, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. British journal of anaesthesia. 2012; aes096. PubMed | Google Scholar

  18. Wikkelsoe AJ, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C, Ekelund K, et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials. 2012; 13(1):110. PubMed | Google Scholar

  19. Roberts I, Ker K. Tranexamic acid for postpartum bleeding. International Journal of Gynecology & Obstetrics. 2011; 115(3):220-1. PubMed | Google Scholar

  20. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. British medical journal. 2012;344:e3054. PubMed | Google Scholar

  21. Ortmann E, Besser M, Klein A. Antifibrinolytic agents in current anaesthetic practice. British journal of anaesthesia. 2013; aet154. PubMed | Google Scholar

  22. Ducloy-Bouthors A-S, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011;15(2):R117. PubMed | Google Scholar

  23. Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. The Cochrane Library. 2010. Google Scholar

  24. Shakur H, Elbourne D, Gülmezoglu M, Alfirevic Z, Ronsmans C, Allen E, et al. Study protocol The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010;11:40. PubMed | Google Scholar

  25. Barillari G, Frigo MG, Casarotto M, Farnia A, Massè B, Wetzl R, et al. Use of recombinant activated factor VII in severe post-partum haemorrhage: data from the Italian Registry: a multicentric observational retrospective study. Thrombosis research. 2009; 124(6):e41-e7. PubMed | Google Scholar

  26. Aya A, Mercier FJ. The role of rFVIIa in treatment of severe post partum haemorrhage to evaluate the risk/benefit ratio. Annales Françaises d’Anesthésie et de Réanimation. 2010; 29(10): 673-5. PubMed | Google Scholar

  27. AFsapps (Agence Française de sécurité sanitaire des produits de santé). Référentiel National de bon usage du Novoseven®. [consulté le 02/04/2014]. Disponible à partir de URL: https://www.santera.fr/doc/omedit/Novoseven/1.%20Novoseven%20PTT.pdf. Google Scholar

  28. Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, et al. The use of recombinant activated FVII in postpartum hemorrhage. Clinical obstetrics and gynecology. 2010;53(1):219-27. PubMed | Google Scholar

  29. Geiger A, Collange O, Samin J, Meyer A, Freys G, Pottecher T, editors. [Efficiency and safety of recombinant activated factor VII in a case of severe postpartum hemorrhage]. Annales françaises d'anesthésie et de réanimation. 2010; 29(10): 728-31. PubMed | Google Scholar

  30. Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000–2004. Obstetrics & Gynecology. 2007; 110(6):1270-8. PubMed | Google Scholar

  31. Solomon C, Collis R, Collins P. Erythrocytes, haemostasis, and coagulation monitoring in postpartum haemorrhage (PPH). British journal of anaesthesia. 2013; 110(6):1054-5. PubMed | Google Scholar

  32. Nielsen HB. Thrombelastography guides transfusion strategy. International journal of biomedical science: IJBS. 2009; 5(2):187. PubMed | Google Scholar

  33. DeLange N, van Rheenen-Flach L, Lancé M, Mooyman L, Woiski M, van Pampus E, et al. Peri-partum reference ranges for ROTEM® thromboelastometry. British journal of anaesthesia. 2014; 112(5):852-9. PubMed | Google Scholar

  34. Solomon C, Collis R, Collins P. Haemostatic monitoring during postpartum haemorrhage and implications for management. British journal of anaesthesia. 2012; 109(6):851-63. PubMed | Google Scholar